These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26944915)

  • 1. Quality of Life in Adults with Neurofibromatosis 1 in Brazil.
    Bicudo NP; de Menezes Neto BF; da Silva de Avó LR; Germano CM; Melo DG
    J Genet Couns; 2016 Oct; 25(5):1063-74. PubMed ID: 26944915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.
    Bicudo NP; Germano CMR; de Moraes RT; de Avó LRDS; Ferner RE; Melo DG
    An Bras Dermatol; 2024; 99(4):520-526. PubMed ID: 38493052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
    Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
    Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.
    Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
    J Genet Couns; 2015 Dec; 24(6):931-44. PubMed ID: 25894096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image.
    Granström S; Langenbruch A; Augustin M; Mautner VF
    Dermatology; 2012; 224(2):160-7. PubMed ID: 22508340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1.
    Cipolletta S; Spina G; Spoto A
    Child Care Health Dev; 2018 Mar; 44(2):260-268. PubMed ID: 28776749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health-related quality of life of children, adolescents, and young adults with neurofibromatosis type 1 and their families: Analysis of narratives.
    Draucker CB; Nutakki K; Varni JW; Swigonski NL
    J Spec Pediatr Nurs; 2017 Apr; 22(2):. PubMed ID: 28198162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families.
    Benjamin CM; Colley A; Donnai D; Kingston H; Harris R; Kerzin-Storrar L
    J Med Genet; 1993 Jul; 30(7):567-74. PubMed ID: 8411029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems.
    Mautner VF; Granström S; Leark RA
    J Atten Disord; 2015 Jan; 19(1):35-43. PubMed ID: 22786884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.
    Cohen JS; Levy HP; Sloan J; Dariotis J; Biesecker BB
    Clin Genet; 2015 Nov; 88(5):425-30. PubMed ID: 25534182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.
    Fjermestad KW; Nyhus L; Kanavin ØJ; Heiberg A; Hoxmark LB
    J Genet Couns; 2018 Sep; 27(5):1102-1110. PubMed ID: 29429039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods.
    Nutakki K; Varni JW; Steinbrenner S; Draucker CB; Swigonski NL
    J Neurooncol; 2017 Mar; 132(1):135-143. PubMed ID: 28078640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.
    Armand ML; Taieb C; Bourgeois A; Bourlier M; Bennani M; Bodemer C; Wolkenstein P;
    Orphanet J Rare Dis; 2019 May; 14(1):94. PubMed ID: 31053133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worries and needs of adults and parents of adults with neurofibromatosis type 1.
    Rietman AB; van Helden H; Both PH; Taal W; Legerstee JS; van Staa A; Moll HA; Oostenbrink R; van Eeghen AM
    Am J Med Genet A; 2018 May; 176(5):1150-1160. PubMed ID: 29681082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: A nationwide study.
    Doser K; Andersen EW; Kenborg L; Dalton SO; Jepsen JRM; Krøyer A; Østergaard J; Hove H; Sørensen SA; Johansen C; Mulvihill J; Winther JF; Bidstrup PE
    Am J Med Genet A; 2020 Jul; 182(7):1704-1715. PubMed ID: 32484306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Appearance in Adolescents' Experiences of Neurofibromatosis Type 1: A Survey of Young People and Parents.
    Barke J; Coad J; Harcourt D
    J Genet Couns; 2016 Oct; 25(5):1054-62. PubMed ID: 27001554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior.
    Krab LC; Oostenbrink R; de Goede-Bolder A; Aarsen FK; Elgersma Y; Moll HA
    J Pediatr; 2009 Mar; 154(3):420-5, 425.e1. PubMed ID: 18950800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1.
    Graf A; Landolt MA; Mori AC; Boltshauser E
    J Pediatr; 2006 Sep; 149(3):348-53. PubMed ID: 16939745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.
    Nutakki K; Hingtgen CM; Monahan P; Varni JW; Swigonski NL
    Health Qual Life Outcomes; 2013 Feb; 11():21. PubMed ID: 23432799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of learning disabilities on the tumour predisposition syndrome NF1--survey from adult patients' perspective.
    Granström S; Friedrich RE; Langenbruch AK; Augustin M; Mautner VF
    Anticancer Res; 2014 Jul; 34(7):3675-81. PubMed ID: 24982386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.